Castle Biosciences’ TissueCypher test informed management changes in 90% of non-dysplastic Barrett’s esophagus cases in a 30-patient study at Keck Medical Center, according to results published in Foregut.
Researchers at CeMM and the Ludwig Boltzmann Institute have developed AI-based “tissue clocks” that estimate organ-specific biological age from blood samples, potentially improving chronic disease monitoring, according to a Nature Medicine study.
The FDA has granted Breakthrough Device Designation to Valar Labs’ Vesta Bladder Risk Stratify Dx, the first AI-powered digital pathology prognostic test for bladder cancer.
The VISQUE DPS LH210 supports up to 210 slides per batch and scans at 23 seconds per slide, expanding Vieworks' digital pathology lineup.
Clarapath has released an updated FDA-registered SectionStar robotic microtomy system, developed with histotechnologists to enhance efficiency and consistency in clinical histology labs amid staffing and case volume challenges.
Peer-reviewed study found 98% concordance between Techcyte's digital workflow and brightfield microscopy in routine clinical laboratory testing.
The newly appointed scientific and medical experts will guide product development, research, regulatory planning, and commercialization.
AMSBIO has expanded its iMatrix series of recombinant laminin E8 fragments to now include laminin isoforms LN-111 and LN-332.
The integration is designed to bridge specimen grossing with digital pathology workflows for improved diagnostic accuracy and efficiency.
Codex technology combines the advantages of single-cell biology with histology at single-cell spatial resolution.